Novalgen Limited

  • Small
  • Holding
  • Active
  • 6 years
  • 17 employees
  • £1,842,350 (assets)
  • Real address
  • 7 directors
  • 1 owner
  • Regular importer

Field of Operation

Research and experimental development on biotechnology
72110 5957 companies

Website

Social media

Summary

Novalgen Limited is a small holding company based in Northwood Hills, UK, with an active status. Founded six years ago in October 2018, it employs seventeen people and holds assets worth £1,842,350. The company has seven directors and one owner, with Convergys Capital Ltd being the owner. Its registered address is real, as only two companies share the same location. Novalgen is a regular importer of miscellaneous chemical products, with recent activity recorded in February 2024.

The company’s website positions Novalgen as a clinical-stage business revolutionizing the immunology landscape. It focuses on developing multispecific antibody therapies to enhance patient outcomes across autoimmune, oncological, and other immunological disorders. The company’s core technology is an autoregulation platform, which aims to create safer drugs by integrating self-regulating capabilities into immunotherapies. The site details a pipeline of antibody therapies, highlights collaborations with research institutions, and showcases news and publications related to its research. It also has a careers page and contact information.

Financially, Novalgen’s numbers paint a mixed picture. Current assets have fallen by nearly half, dropping to £1,100,000, while net assets have also seen a significant decrease, falling 20% to -£22,000,000. Bank cash has plummeted 75%, leaving just £680,000. However, creditors have increased by 64%, reaching £790,000, and trade debtors have risen by 29%, suggesting a possible need for working capital. The company's small size (meeting two of three conditions for being a small company) helps it remain agile, but the substantial drop in equity raises concerns. The company’s financial statements are unaudited, as it is exempt from an audit as a small company.

Overall, Novalgen appears to be facing financial pressures, despite its innovative research and development focus. Whether it can secure funding or partnerships to sustain its operations remains to be seen.

Registered in England/Wales under the registration number 11621264, with a registered address at HA6 1NW, England, Northwood Hills, Middlesex, Argyle House Level 3 Northside, Joel Street.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.

Owners & PSC

  • 6 years
  • 1
  • 25%+

Managers

  • 2 years
  • 4
Director
Director
  • 2 years
  • 2
Non-executive director
  • 2 years
Ceo
  • 5 years
  • 5
Ceo & president of r&d
See other directors

Last reports

Download the last financial report
Download the last confirmation report
* may contain a full shareholder list

Last news

  1. Statement of capital following an allotment of shares on 2025-06-27
  2. Statement of capital following an allotment of shares on 2025-06-27
  3. Statement of capital following an allotment of shares on 2025-05-30
See all events

Novalgen Limited controls

Owns & Controls

  • 4 years
  • 75%+
  • 4 years
  • 75%+
  • 4 years
  • 75%+
  • 6 years
  • 75%+

Importer profile by HS codes

Click on the map to see detailed UK statistics on HS code, including companies list.

Last imported products

Click on items to see detailed UK statistics on HS code, including companies list.

Similar importers

Buy the list of 979 UK B2B buyers of miscellaneous chemical products.
  • Company names
  • HS codes
  • Financial data
  • Officers and owners
*from 99$

FAQ about Novalgen Limited

Looking for leads in the UK?

Try our FREE App—access UK datasets with limited features!

Similar companies